Stock ICUGS ICU GIRISIM SERMAYESI YATIRIM ORTAKLIGI
Add to a list
To use this feature you must be a member
Log inSign up

Financials ICU Girisim Sermayesi Yatirim Ortakligi

Equities

ICUGS

TRAVKFRS91Q0

Investment Management & Fund Operators

Delayed Borsa Istanbul
Other stock markets
 04:52:46 2024-06-27 EDT 		5-day change 1st Jan Change
12.27 TRY +1.32% Intraday chart for ICU Girisim Sermayesi Yatirim Ortakligi -7.33% +18.67%
06-21 ICU Girisim Sermayesi Yatirim Ortakligi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 ICU Girisim Sermayesi Yatirim Ortakligi A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 186.6 429.6
Enterprise Value (EV) 1 179.2 277.7
P/E ratio -16.5 x -57.9 x
Yield - -
Capitalization / Revenue - 32,510,780 x
EV / Revenue - 21,016,879 x
EV / EBITDA -21.4 x -1,011 x
EV / FCF - 198,234,710 x
FCF Yield - 0%
Price to Book 3.44 x 9.33 x
Nbr of stocks (in thousands) 41,550 41,550
Reference price 2 4.490 10.34
Announcement Date 4/22/24 4/22/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - 13.21
EBITDA 1 -8.388 -0.2748
EBIT 1 -8.454 -0.3299
Operating Margin - -2.5%
Earnings before Tax (EBT) 1 -11.28 -6.721
Net income 1 -11.28 -7.417
Net margin - -56.13%
EPS 2 -0.2714 -0.1785
Free Cash Flow - 1.401
FCF margin - 10.6%
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 4/22/24 4/22/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - -
Net Cash position 1 7.4 152
Leverage (Debt/EBITDA) - -
Free Cash Flow - 1.4
ROE (net income / shareholders' equity) - -14.8%
ROA (Net income/ Total Assets) - -0.11%
Assets 1 - 6,737
Book Value Per Share 2 1.300 1.110
Cash Flow per Share 2 1.120 0.5800
Capex - 0.32
Capex / Sales - 2.45%
Announcement Date 4/22/24 4/22/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Venture Capital

1st Jan change Capi.
ICU GIRISIM SERMAYESI YATIRIM ORTAKLIGI Stock ICU Girisim Sermayesi Yatirim Ortakligi
+18.67% 25.62M
HERCULES CAPITAL, INC. Stock Hercules Capital, Inc.
+20.88% 3.22B
UMBRA COMPANIES INC. Stock Umbra Companies Inc.
+12.50% 1.76B
HBM HEALTHCARE INVESTMENTS AG Stock HBM Healthcare Investments AG
+9.31% 1.57B
OCTOPUS TITAN VCT PLC Stock Octopus Titan VCT plc
-11.54% 1.22B
MOLTEN VENTURES PLC Stock Molten Ventures Plc
+34.91% 887M
CION INVESTMENT CORPORATION Stock CION Investment Corporation
+6.98% 648M
VERUSA HOLDING Stock Verusa Holding
+58.63% 649M
OCTOPUS APOLLO VCT PLC Stock Octopus Apollo VCT plc
-4.17% 502M
WOORI TECHNOLOGY INVESTMENT CO., LTD Stock Woori Technology Investment Co., Ltd
+20.19% 433M
Venture Capital
  1. Stock Market
  2. Equities
  3. ICUGS Stock
  4. Financials ICU Girisim Sermayesi Yatirim Ortakligi